MAT9001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MAT9001, covering 2021-09-16 to 2021-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL [Phase 3]